Company · CIK 1640455
Jounce Therapeutics, Inc.
| CIK | 1640455 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2017-03-10 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-223518 | 2018-03-08 | 2023-05-04 | 6 | |
| 333-255760 | 2021-05-04 | 2023-05-04 | 4 | |
| 333-215372 | 2016-12-30 | 2017-01-27 | 4 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-05-04 | EFFECTDeclared effective | 333-255760 | 9999999995-23-001276 |
| 2023-05-04 | EFFECTDeclared effective | 333-223518 | 9999999995-23-001275 |
| 2021-11-04 | 424B5Shelf takedown | 333-255760 | 0001640455-21-000149 |
| 2021-05-19 | EFFECTDeclared effective | 333-255760 | 9999999995-21-002009 |
| 2021-05-04 | S-3Shelf registered | 333-255760 | 0001640455-21-000095 |
| 2021-03-10 | 424B5Shelf takedown | 333-223518 | 0001640455-21-000066 |
| 2021-03-09 | 424B5Shelf takedown | 333-223518 | 0001640455-21-000061 |
| 2019-12-17 | 424B5Shelf takedown | 333-223518 | 0001640455-19-000091 |
| 2018-05-01 | EFFECTDeclared effective | 333-223518 | 9999999995-18-001058 |
| 2018-03-08 | S-3Shelf registered | 333-223518 | 0001640455-18-000034 |
| 2017-01-27 | 424B4Final prospectus | 333-215372 | 0001047469-17-000398 |
| 2017-01-26 | EFFECTDeclared effective | 333-215372 | 9999999995-17-000220 |
| 2017-01-17 | S-1/AAmendment | 333-215372 | 0001047469-17-000189 |
| 2016-12-30 | S-1Registration filed | 333-215372 | 0001047469-16-017325 |
| 2015-11-06 | DRSDraft made public | 377-01199 | 0000912057-15-000380 |